ID   E95C-BL-41
AC   CVCL_C5V7
DR   Wikidata; Q116048917
RX   PubMed=2645221;
RX   PubMed=3037521;
CC   Population: Caucasian.
CC   Virology: EBV-negative cell line infected with EBV strain B95-8 (PubMed=3037521).
CC   HLA typing: A*32; B*35,49 (PubMed=3037521).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Unspecified (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Cell type: B-cell; CL=CL_0000236.
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1087 ! BL-41
SX   Male
AG   8Y
CA   Cancer cell line
DT   Created: 15-12-22; Last updated: 02-05-24; Version: 3
//
RX   PubMed=2645221; DOI=10.1002/ijc.2910430219;
RA   Torsteinsdottir S., Andersson M.L., Avila-Carino J.,
RA   Ehlin-Henriksson B., Masucci M.G., Klein G., Klein E.;
RT   "Reversion of tumorigenicity and decreased agarose clonability after
RT   EBV conversion of an IgH/myc translocation-carrying BL line.";
RL   Int. J. Cancer 43:273-278(1989).
//
RX   PubMed=3037521; DOI=10.1073/pnas.84.13.4567;
RA   Masucci M.G., Torsteinsdottir S., Colombani J., Brautbar C., Klein E.,
RA   Klein G.;
RT   "Down-regulation of class I HLA antigens and of the Epstein-Barr
RT   virus-encoded latent membrane protein in Burkitt lymphoma lines.";
RL   Proc. Natl. Acad. Sci. U.S.A. 84:4567-4571(1987).
//